Trovagene Advances Next-Gen Version Of Qiagen’s HPV Test – Seeking Alpha

Trovagene Advances Next-Gen Version Of Qiagen's HPV Test
Seeking Alpha
With the announcement of the commercial availability of their urine-based HPV test, Trovagene (TROV) has taken their first steps to capitalizing on the ever-growing market of Human Papillomavirus screening. As I pointed out in my previous article (read
Trovagene launches HPV assayPharmaceutical Business Review
Trovagene, Inc., Announces Fourth Quarter and Year End 2012 EarningsPR Newswire (press release)

all 3 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *